Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01192477 · ClinicalTrials.gov registry record · NA

Ozone Cardiovascular Effects in Genetically Susceptible People

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01192477 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01192477, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Increases in air pollution are associated with increases in deaths from cardiovascular disease, but the investigators know little about how ozone air pollution affects the cardiovascular system. The investigators proposed study will determine the effects of ozone on blood vessel and heart function that could worsen illness in people with underlying heart disease. This will be accomplished by studying healthy volunteers who inhale ozone in a controlled clinical study, and also by studying their exposure to ozone and other pollutants during their normal daily activities. The investigators will study volunteers who may be at increased risk for the effects of ozone because of genetic susceptibility. Understanding the effects of ozone on the heart and circulation can help establish appropriate air pollution standards, and provide strategies to protect the most susceptible people.

Interventions

  • OTHER Ozone

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2011-05
Est. Completion 2012-08
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT01192477

The ClinicalTrials.gov registry entry for NCT01192477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Ozone is the first listed.

NCT01192477 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01192477 about?

NCT01192477 is a clinical study titled "Ozone Cardiovascular Effects in Genetically Susceptible People". Increases in air pollution are associated with increases in deaths from cardiovascular disease, but the investigators know little about how ozone air pollution affects the cardiovascular system. The investigators proposed study will determine the effects of ozone on blood vessel and heart function t...

What is the current status of trial NCT01192477?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2011-05. Estimated completion is 2012-08.

What interventions are being tested in trial NCT01192477?

The interventions under investigation include: Ozone (OTHER).

Who is sponsoring clinical trial NCT01192477?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.